Long-Term Gender-Based Outcomes for Atazanavir/Ritonavir (ATV/r)- Containing Regimens in Treatment-Experienced Patients with HIV

Publisher： Bentham Science Publishers

E-ISSN： 1873-4251|11|4|333-341

ISSN： 1570-162X

Source： Current HIV Research, Vol.11, Iss.4, 2013-06, pp. : 333-341

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunological and Virological Outcomes of Patients Switched from LPV/r to ATV/r-Containing Second- Line Regimens

By  

Current HIV Research, Vol. 13, Iss. 3, 2015-05 ,pp. : 176-183

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of advanced HIV disease in antiretroviral-naïve HIV-1-infected patients receiving once-daily atazanavir/ritonavir or twice-daily lopinavir/ritonavir, each in combination with tenofovir disoproxil fumarate and emtricitabine

By Uy Jonathan   Yang Rong   Wirtz Victoria   Sheppard Louise   Farajallah Awny   McGrath Donnie  

AIDS Care, Vol. 23, Iss. 11, 2011-11 ,pp. : 1500-1504

Routledge Ltd

Access to resources Recommend Favorite

The Use of Nucleoside Reverse Transcriptase Inhibitors Sparing Regimens in Treatment-Experienced HIV-1 Infected Patients

By  

Current HIV Research, Vol. 11, Iss. 3, 2013-04 ,pp. : 179-186

Bentham Science Publishers

Access to resources Recommend Favorite

Sialolithiasis in an HIV-1-infected patient treated with atazanavir/ritonavir monotherapy

By Lê Minh P.   Stitou Hind   Soulie Cathia   Katlama Christine   Peytavin Gilles  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 3, 2013-03 ,pp. : 727-729

Oxford University Press

Access to resources Recommend Favorite

The DUET trials: etravirine in the management of treatment-experienced HIV-1-infected patients

By Mills Anthony M  

HIV Therapy, Vol. 4, Iss. 3, 2010-05 ,pp. : 265-280

Future Medicine

Access to resources Recommend Favorite